AU628653B2 - Novel cns-active hexapeptides with an antiamnesic effect - Google Patents

Novel cns-active hexapeptides with an antiamnesic effect

Info

Publication number
AU628653B2
AU628653B2 AU63064/90A AU6306490A AU628653B2 AU 628653 B2 AU628653 B2 AU 628653B2 AU 63064/90 A AU63064/90 A AU 63064/90A AU 6306490 A AU6306490 A AU 6306490A AU 628653 B2 AU628653 B2 AU 628653B2
Authority
AU
Australia
Prior art keywords
denotes
hexapeptides
active
lys
met
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU63064/90A
Other versions
AU6306490A (en
Inventor
Hermann Josef Gerhards
Franz Hock
Georg Jager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU6306490A publication Critical patent/AU6306490A/en
Application granted granted Critical
Publication of AU628653B2 publication Critical patent/AU628653B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]

Abstract

The present invention relates to hexapeptides of the general formula I R<1>-A<1>-A<2>-A<3>-A<4>-A<5>-A<6>-NH(CH2)n-NH2 (I> where R<1> denotes Z, formyl or (subst.) alkanoyl; A<1> denotes Met, Met(O) or Met(O2), all of which can be in the L or D form; A<2> denotes Glu, D-Glu, Ala or pyroglutamyl; A<3> denotes His, Ala, Phe or D-Lys; A<4> denotes the radical of a neutral aliphatic or aromatic alpha -amino acid; A<5> denotes Lys or D-Lys; A<6> denotes (subst.) Phe and n denotes an integer from 4 to 10. Processes for the preparation thereof, the use thereof as medicines, and pharmaceutical compositions containing these are described.
AU63064/90A 1989-09-23 1990-09-21 Novel cns-active hexapeptides with an antiamnesic effect Ceased AU628653B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3931788A DE3931788A1 (en) 1989-09-23 1989-09-23 NEW CNS ACTIVE HEXAPEPTIDES WITH ANTIAMNESTIC EFFECT
DE3931788 1989-09-23

Publications (2)

Publication Number Publication Date
AU6306490A AU6306490A (en) 1991-03-28
AU628653B2 true AU628653B2 (en) 1992-09-17

Family

ID=6390039

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63064/90A Ceased AU628653B2 (en) 1989-09-23 1990-09-21 Novel cns-active hexapeptides with an antiamnesic effect

Country Status (11)

Country Link
EP (1) EP0424670B1 (en)
JP (1) JPH03120295A (en)
AT (1) ATE118786T1 (en)
AU (1) AU628653B2 (en)
CA (1) CA2025941A1 (en)
DE (2) DE3931788A1 (en)
DK (1) DK0424670T3 (en)
ES (1) ES2070229T3 (en)
GR (1) GR3015492T3 (en)
IE (1) IE66529B1 (en)
PT (1) PT95381B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106608901B (en) * 2015-10-22 2020-10-16 彭莉 Dihydroxydimethyltetrahydroisoquinoline-3-formyl-Lys (Lys-Ala), and synthesis, activity and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179332A2 (en) * 1984-10-22 1986-04-30 Hoechst Aktiengesellschaft ZNS-active peptides acting on the cholinergetic system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758206A (en) * 1969-10-31 1971-04-29 Hoechst Ag PEPTIDES WITH ADRENOCORTICOTROPIC ACTIVITY AND MEDICINAL PRODUCTS CONTAINING IT
DE1965102A1 (en) * 1969-12-27 1971-07-01 Hoechst Ag Tridecapeptides with adrenocorticotropic - activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179332A2 (en) * 1984-10-22 1986-04-30 Hoechst Aktiengesellschaft ZNS-active peptides acting on the cholinergetic system

Also Published As

Publication number Publication date
EP0424670A1 (en) 1991-05-02
CA2025941A1 (en) 1991-03-24
DE3931788A1 (en) 1991-04-04
DE59008515D1 (en) 1995-03-30
IE903420A1 (en) 1991-04-10
PT95381A (en) 1991-05-22
IE66529B1 (en) 1996-01-17
PT95381B (en) 1997-07-31
GR3015492T3 (en) 1995-06-30
AU6306490A (en) 1991-03-28
ES2070229T3 (en) 1995-06-01
ATE118786T1 (en) 1995-03-15
JPH03120295A (en) 1991-05-22
DK0424670T3 (en) 1995-07-17
EP0424670B1 (en) 1995-02-22

Similar Documents

Publication Publication Date Title
AU633913B2 (en) Novel tnf-inhibit proteins and their preparation
DE69627704D1 (en) Protegrine
UA35636C2 (en) Polypeptide possessing lung surfactant activity and pharmaceutical composition for treating respiratory distress syndrome in mammals
IL104325A (en) Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
DE69429176D1 (en) Protegrine
HK1014548A1 (en) Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
WO2000012542A3 (en) Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
NZ214122A (en) Analgesic dynorphin-like hepta and octa and nona and deca peptides
IL104314A0 (en) Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
BR9807618A (en) Xdelta factor analogue, recombinant DNA encoding an xdelta factor analogue, transformed cells, preparation, use thereof, and processes for producing a preparation containing purified recombinant factor xdelta analogue and factor xa analogue.
AU3394793A (en) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
FI892185A0 (en) A process for the preparation of therapeutically useful peptide compounds
ES2015366A6 (en) Elastase inhibiting polypeptides and process for their preparation by genetic recombination.
AU568866B2 (en) Preparation of insulin derivatives
TW224975B (en)
AU9026691A (en) New human recombinant gamma interferon
AU628653B2 (en) Novel cns-active hexapeptides with an antiamnesic effect
HRP940432B1 (en) Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
ES2007110A6 (en) Insulin precursors.
ES8605769A1 (en) Peptides.
WO1990003394A3 (en) New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
GB9604518D0 (en) Novel compounds
GEP19981435B (en) Peptides with Organo-Protective Activity, Pharmaceutical Composition and the Use Thereof
RU94036770A (en) Protease inhibitor domain, dna, cell, method of domain preparing, pharmaceutical composition, domain use